Recent interim analysis of the HD11 trial of the GHSG: intensification of chemotherapy and reduction of radiation dose in early unfavorable stage Hodgkin's lymphoma.

V Diehl; C Brillant; A Engert; RP Mueller; HT Eich; K Mueller-Hermelink; R Herrmann; J Markova; A Ho; W Hiddemann; B Doerken; Richard Greil; A Josting; B Pfistner

Recent interim analysis of the HD11 trial of the GHSG: intensification of chemotherapy and reduction of radiation dose in early unfavorable stage Hodgkin's lymphoma.

V Diehl, C Brillant, A Engert, RP Mueller, HT Eich, K Mueller-Hermelink, R Herrmann, J Markova, A Ho, W Hiddemann, B Doerken, Richard Greil, A Josting, B Pfistner

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	816
Journal	BLOOD
Volume	106
Issue number	11
Publication status	Published - 2005
Event	47th Annual Meeting of the American Society of Hematology (ASH) - Atlanta, Georgia, United States Duration: 10 Dec 2005 → 13 Dec 2005

1 Poster

Recent interim analysis of the HD11 trial of the GHSG: intensification of chemotherapy and reduction of radiation dose in early unfavorable stage Hodgkin's lymphoma.
Diehl, V., Brillant, C., Engert, A., Mueller, R., Eich, H., Mueller-Hermelink, K., Herrmann, R., Markova, J., Ho, A., Hiddemann, W., Doerken, B., Greil, R., Josting, A. & Pfistner, B., 2005.
Research output: Contribution to conference › Poster

Cite this

Diehl, V., Brillant, C., Engert, A., Mueller, RP., Eich, HT., Mueller-Hermelink, K., Herrmann, R., Markova, J., Ho, A., Hiddemann, W., Doerken, B., Greil, R., Josting, A., & Pfistner, B. (2005). Recent interim analysis of the HD11 trial of the GHSG: intensification of chemotherapy and reduction of radiation dose in early unfavorable stage Hodgkin's lymphoma. BLOOD , 106(11), 816.

Diehl, V ; Brillant, C ; Engert, A et al. / Recent interim analysis of the HD11 trial of the GHSG: intensification of chemotherapy and reduction of radiation dose in early unfavorable stage Hodgkin's lymphoma. In: BLOOD 2005 ; Vol. 106, No. 11. pp. 816.

@article{65541080135c44dbbb063fc135e1adbe,

title = "Recent interim analysis of the HD11 trial of the GHSG: intensification of chemotherapy and reduction of radiation dose in early unfavorable stage Hodgkin's lymphoma.",

author = "V Diehl and C Brillant and A Engert and RP Mueller and HT Eich and K Mueller-Hermelink and R Herrmann and J Markova and A Ho and W Hiddemann and B Doerken and Richard Greil and A Josting and B Pfistner",

year = "2005",

language = "English",

volume = "106",

pages = "816",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "11",

note = "47th Annual Meeting of the American Society of Hematology (ASH) ; Conference date: 10-12-2005 Through 13-12-2005",

}

Diehl, V, Brillant, C, Engert, A, Mueller, RP, Eich, HT, Mueller-Hermelink, K, Herrmann, R, Markova, J, Ho, A, Hiddemann, W, Doerken, B, Greil, R, Josting, A & Pfistner, B 2005, 'Recent interim analysis of the HD11 trial of the GHSG: intensification of chemotherapy and reduction of radiation dose in early unfavorable stage Hodgkin's lymphoma.', BLOOD , vol. 106, no. 11, pp. 816.

Recent interim analysis of the HD11 trial of the GHSG: intensification of chemotherapy and reduction of radiation dose in early unfavorable stage Hodgkin's lymphoma. / Diehl, V; Brillant, C; Engert, A et al.
In: BLOOD , Vol. 106, No. 11, 2005, p. 816.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Recent interim analysis of the HD11 trial of the GHSG: intensification of chemotherapy and reduction of radiation dose in early unfavorable stage Hodgkin's lymphoma.

AU - Diehl, V

AU - Brillant, C

AU - Engert, A

AU - Mueller, RP

AU - Eich, HT

AU - Mueller-Hermelink, K

AU - Herrmann, R

AU - Markova, J

AU - Ho, A

AU - Hiddemann, W

AU - Doerken, B

AU - Greil, Richard

AU - Josting, A

AU - Pfistner, B

PY - 2005

Y1 - 2005

M3 - Abstract (Journal)

SN - 0006-4971

VL - 106

SP - 816

JO - BLOOD

JF - BLOOD

IS - 11

T2 - 47th Annual Meeting of the American Society of Hematology (ASH)

Y2 - 10 December 2005 through 13 December 2005

ER -

Diehl V, Brillant C, Engert A, Mueller RP, Eich HT, Mueller-Hermelink K et al. Recent interim analysis of the HD11 trial of the GHSG: intensification of chemotherapy and reduction of radiation dose in early unfavorable stage Hodgkin's lymphoma. BLOOD . 2005;106(11):816.